DISCOVER
eISF
THE ELECTRONIC INVESTIGATOR SITE FILE
The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements. These documents include the protocol, informed consent forms, study reports, lab results, and other documentation related to the trial.
Leads to this page
The eISF is stored in a secure, web-based system that is accessible to authorized personnel only
The use of eISFs has several advantages over paper-based ISFs :
• efficiency in document management
• increases accuracy and completeness of data
• enhances security of sensitive information
• facilitates remote monitoring of study sites
• real-time data access and sharing between sites, sponsors, and regulatory agencies
Theuse of eISFs represents a significant step forward in the conduct of clinical research, enabling faster and more efficient trial management while ensuring compliance with regulatory and ethical standards.
LATEST NEWSOUR NEWS >
March 29, 2024
April 10 & 11, 2024 Telemedicine Technologies and OVHcloud are partnering to host health data collected in hospitals for medical research studies using the CleanWeb™ software suite. This collaboration allows Telemedicine Technologies to benefit from OVHcloud’s support, including 24/7 assistance and guarantees such as data localisation in France and transparency in data processing practices. DMEA […]
March 29, 2024
Applied Clinical Trials Online A lack of diversity in clinical trials is a critical issue, as racial and ethnic subgroups may respond differently to therapies, potentially undermining efficacy and safety outcomes and producing results that are not representative of the patients who will receive the treatment in the real world. Furthermore, clinical trials provide access […]
March 29, 2024
Mind health The startup Metafora Biosystems, which develops a platform for cellular metabolism analysis, announced on March 11th the reimbursement approval in France for its METAglut1 test, aiding in the diagnosis of Glut1 transporter deficiency syndrome since February 15th. This blood-based test is less invasive than the previously preferred lumbar puncture. It’s the first healthcare […]